Annual Shareholders' Meeting Results


Auckland, New Zealand, 28 August 2019 - Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed. The seven resolutions were: 

Resolution 1: To re-elect Lewis Gradon as a Director. 

Resolution 2: To re-elect Donal O’Dwyer as a Director. 

Resolution 3: To elect Neville Mitchell as a Director. 

Resolution 4: To authorise the Directors to fix the fees and expenses of the Company’s auditor. 

Resolution 5: To approve the issue of share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2019. 

Resolution 6: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2019. 

Resolution 7: To revoke the Company’s current constitution and adopt an updated constitution. 

All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
 
Resolution Votes For % Votes Against Total Votes Cast Abstain
Resolution 1 Re-election of Lewis Gradon 366,211,794 99.99 34,786 366,506,224 259,644
Resolution 2: Re-election of Donal O’Dwyer 362,028,570 98.84 4,255,366 366,506,224 222,288
Resolution 3: Election Neville Mitchell 366,310,274 99.99 27,823 366,506,224 168,127
Resolution 4: Authorise Directors to fix fees and expenses of auditor 366,032,085 99.92 304,778 366,506,224 169,361
Resolution 5: Issue of share rights to Lewis Gradon 340,475,664 93.13 25,123,366 365,902,722 303,692
Resolution 6: Issue of options to Lewis Gradon 338,904,512 92.70 26,669,393 365,902,722 328,817
Resolution 7: Revoke constitution and adopt updated constitution 366,139,655 99.98 72,793 366,506,224 293,776


Contact: Marcus Driller, VP – Corporate and Company Secretary on +64 9 574 0110. For more information about the company visit our website www.fphcare.com

 

About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Investors:

Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073

 

Media:

Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 (0) 21 713 911